Ifosfamide (Pfizer Laboratories Div Pfizer Inc.)
Welcome to the PulseAid listing for the Ifosfamide drug offered from Pfizer Laboratories Div Pfizer Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc. |
| NON-PROPRIETARY NAME: | Ifosfamide |
| SUBSTANCE NAME: | IFOSFAMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-11-27 |
| END MARKETING DATE: | 0000-00-00 |
Ifosfamide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ifosfamide from Pfizer Laboratories Div Pfizer Inc. |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2012-11-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0069-4495_4bb31494-d895-4d80-a72a-c80aff94f402 |
| PRODUCT NDC: | 0069-4495 |
| APPLICATION NUMBER: | ANDA201689 |
Other IFOSFAMIDE Pharmaceutical Manufacturers / Labelers:
